论文部分内容阅读
【目的】观察中西医结合疗法对慢性阻塞性肺病(COPD)稳定期患者预后指标(BODE)的影响。【方法】将60例COPD病情分级为Ⅰ～Ⅱ级的稳定期患者随机分为治疗组和对照组。对照组给予长效茶碱(舒氟美)口服,治疗组在口服舒氟美的基础上加服具有培土生金功效的中药汤剂(党参、五爪龙、茯苓、白术、淮山、五味子、款冬花、北杏仁、桃仁、紫苏子、鸡内金、甘草),疗程6个月,比较2组对COPD稳定期患者BODE的影响。【结果】治疗6个月后,治疗组BODE总积分及等级均较治疗前显著改善(与治疗前比较,P<0.05);治疗后组间比较,差异均有显著性意义(P<0.05),提示治疗组的治疗方案在改善BODE方面优于对照组。【结论】采用具有培土生金功效的中药配合西药的治疗方案能够较好地改善COPD稳定期患者的预后指标。
【Objective】 To observe the effect of integrated traditional Chinese and Western medicine on the prognosis index (BODE) of patients with chronic obstructive pulmonary disease (COPD). 【Methods】 Sixty COPD patients with stable stage Ⅰ ~ Ⅱ were randomly divided into treatment group and control group. The control group was given long-acting theophylline (Shifmei) orally, and the treatment group was given traditional Chinese medicine decoction (Codonopsis, Gynostemma, Poria, Atractylodes, Yam, Schisandra, Coltsfoot Flowers, North almonds, peach kernel, perilla, chickweed, licorice) for 6 months. The effects of two groups on BODE in stable COPD patients were compared. 【Results】 After 6 months of treatment, the total score and grade of BODE in the treatment group were significantly improved compared with those before treatment (P <0.05 compared with before treatment), and there was significant difference between the two groups after treatment (P <0.05) , Suggesting that the treatment group’s treatment plan is better than the control group in improving BODE. 【Conclusion】 The treatment of traditional Chinese medicine with Chinese medicinal herbs that has the effect of promoting the growth of native gold can improve the prognosis of patients with stable COPD.